Definitive Contract HHS261031019

This federal contract award supports a research study examining the relationship between radiation dose-response and the development of secondary primary cancers, specifically focusing on stomach, esophagus, and pancreatic cancers among cancer survivors. The project, valued at $282,418, operates under a definitive cost-no-fee contract structure, with performance taking place in Denmark. The award was executed on September 30, 2003, with an ultimate completion date of September 29, 2005. No set-aside designation was applied to this procurement.

Based on the contract parameters, this research initiative likely falls under the purview of a National Institutes of Health agency, such as the National Cancer Institute, which regularly funds epidemiological studies addressing cancer survivorship and late effects of cancer treatment. The study represents an investment in understanding long-term health outcomes for cancer survivors, with particular emphasis on quantifying radiation-related risks for secondary malignancies in vulnerable anatomical sites. The international location of performance in Denmark suggests collaboration with a foreign research institution or organization with established expertise in cancer survivor cohort studies and radiation dose assessment methodologies.